Download Reference-List-AAW-2015-Powerpoint

Reference List: “Antibiotics. Handle with Care”.
PowerPoint Presentation for Australian Antibiotic Awareness Week 2015
1. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States in the 20th
century. Journal of the American Medical Association 1999; 281(1):61-66. (Available online in full text at
http://jama.jamanetwork.com/article.aspx?articleid=768249
2. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher H, Scheld WM, Bartlett JG, and Edwards J. The
epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious
Diseases Society of America. Clinical Infectious Diseases 2008; 46:(2) 155-164.
3. Gottlieb T and Nimmo GR. Antibiotic resistance is an emerging threat to public health: an urgent call to
action at the Antimicrobial Resistance Summit 2011. Medical Journal of Australia 2011; 194 (6): 281-3
4. Fleming A. Penicillin Nobel Lecture, December 11, 1945
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf
5. Pray LA. Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial
Incentive, Insight Pharma Reports 2008, in Looke D. The Real Threat of Antibiotic Resistance [online
presentation]. http://www.health.qld.gov.au/chrisp/education/AMS_Forum_Looke.pdf (accessed 30 Oct
12)
6. Centers for Disease Control and Prevention. Access at http://www.cdc.gov/hai/
7. Glen’s story access at http://www.hha.org.au/ForHealthcareWorkers/education.aspx
8. Magiorakos AP, Srinivasan A. Multidrug-resistant, extensively drug-resistant and pandrug-resistant
bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical
Microbiology and Infection 2012; 18 (3): 268–81
9. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella
GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobialresistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical
Infectious Diseases 2009; 49:1175–1184.
10. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. Access at
http://www.who.int/drugresistance/documents/surveillancereport/en/
11. World Health Organization 2015. Action agenda for antimicrobial resistance in the Western Pacific
Region. Access at: http://www.wpro.who.int/entity/drug_resistance/policy/en/ last accessed 8 Sept. 2015
12. Mendes RE, Mendoza M, Banga Singh KK, Castanheira M, Bell JM, Turnidge JD, Lin SSF, Jones RN.
“Regional Resistance Surveillance Program Results for Twelve Asia-Pacific Nations (2011)”. Antimicrobial
Agents and Chemotherapy. Published ahead of print 19 August 2013, doi:10.1128/AAC.01121-13.
13. Xiao YH, Giske CG, Wei ZQ, Shen P, Heddini A, Li LJ. Epidemiology and characteristics of antimicrobial
resistance in China. Drug Resistance Updates: Reviews and Commentaries. In Antimicrobial and
Anticancer Chemotherapy. 2011 Aug-Oct; Vol. 14(4-5), pp. 236-50. Date of Electronic Pub: 2011 Jul 31.
14. Chong Y, Yakushiji H, Ito Y, Kamimura T. Clinical and molecular epidemiology of extended-spectrum ßlactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan.
European Journal of Clinical Microbiology and Infectious Diseases, 2011; 30 (1), pp 83-87.
REFERENCES: 2015 Antibiotic Awareness Week Presentation: Antibiotics. Handle with Care.
Available at www.safetyandquality.gov.au/AAW
1
15. Looke DL, Gottlieb T, Jones CA and Paterson DL (2013) Gram-negative resistance: can we combat the
coming of a new “Red Plague”? Medical Journal of Australia. 198 (5): 243-4
16. Harris P, Paterson D, Rogers B. Facing the challenge of multidrug-resistant gram-negative bacilli in
Australia. Medical Journal of Australia. 2015; 202(5): 243-7.
17. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M,
and the European Antimicrobial Resistance Surveillance System and European Surveillance of
Antimicrobial Consumption Project Groups. Antimicrobial drug use and resistance in Europe. Emerging
Infectious Diseases 2008; 14(11):1722-1730
18. Commonwealth of Australia 2015 Antimicrobial use in Australian hospitals: 2014 annual report of the
National Antimicrobial Utilisation Surveillance Program
http://www.safetyandquality.gov.au/publications/antimicrobial-use-in-australian-hospitals-2014-report-ofthe-national-antimicrobial-utilisation-surveillance-program/
19. National Antimicrobial Utilisation Surveillance Program (NAUSP) – unpublished data
20. Duguid M, Cruickshank M (editors). Antimicrobial Stewardship in Australian Hospitals. Sydney: Australian
Commission on Safety and Quality in Health Care, 2011.
21. Australian Commission on Safety and Quality in Health Care (2015). Antimicrobial prescribing practice in
Australian hospitals: results of the 2014 National Antimicrobial Prescribing Survey, ACSQHC, Sydney.
22. Commonwealth of Australia 2015 Antimicrobial use in Australian hospitals: 2014 annual report of the
National Antimicrobial Utilisation Surveillance Program
23. Adapted from Spellberg B et al. The epidemic of antibiotic resistant infections: A call to action for the
medical community from the Infectious Diseases Society of America. Clinical Infectious Diseases 2008;
46(2):155-64
24. Spellberg B. New antibiotic development: barriers and opportunities in 2012. APUA Clinical Newsletter
2012; 30(1):8-10
25. Commonwealth of Australia. National Antimicrobial Resistance Strategy. 2015. Access at:
www.health.gov.au/amr
26. Nathwani D and Sneddon J. Practical Guide to Antimicrobial Stewardship. Access at
http://bsac.org.uk/news/practical-guide-to-antimicrobial-stewardship-in-hospitals/
27. Australian Commission on Safety and Quality in Health Care. National Safety and Quality Health Service
Standards. Sydney. ACSQHC 2011.
28. Australian Commission on Safety and Quality in Health Care. Antimicrobial Stewardship Clinical Care
Standard. Sydney: ACSQHC, 2014
29. Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic
Guidelines Limited; 2014.
30. Dr Margaret Chan, Keynote address at the conference on Combating antimicrobial resistance: time for
action. Copenhagen, Denmark 14 March 2012. Accessed 29/10/2015 at
http://www.who.int/dg/speeches/2012/amr_20120314/en/
REFERENCES: 2015 Antibiotic Awareness Week Presentation: Antibiotics. Handle with Care.
Available at www.safetyandquality.gov.au/AAW
2